Comparison of Diagnostic Performance of an Algorithm and a High Definition Classical Iterative Algorithm Positron Emission Tomography (PET) to 18Fluoro-deoxy-glucose (18FDG) in the Evaluation of Axillary Lymph Node Invasion of Breast Tumors
- Conditions
- Breast Cancer
- Registration Number
- NCT01436591
- Lead Sponsor
- Centre Francois Baclesse
- Brief Summary
The primary endpoint of this study is to show that this algorithm in high definition is superior to the classical algorithm in the diagnosis of lymph node metastases.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 63
- Informed consent and signed by the patient
- Age ≥ 18 years
- Breast tumor for which the therapeutic indication for surgery has from the outset: breast surgery (conservative or radical) associated with a conventional axillary dissection
- Proof of infiltrating ductal carcinoma histology
- No known metastasis
- No cons-indication to anesthesia.
Exclusion criteria:
- History of neoadjuvant therapy
- Patients with invasive lobular carcinoma
- Indication of the use of sentinel node (if invasive carcinoma uni-centric, ≤ 2 cm in diameter, without palpable lymphadenopathy (N0))
- Diabetes is not controlled by conventional treatment (blood glucose> 1.8 g / l)
- Inability to capital
- Patients who are pregnant or nursing or of childbearing potential and not using adequate contraception
- Persons deprived of their liberty
- Major subject of a measure of legal protection or unable to consent
- Refusal to participate
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Performance of FDG-PET for the evaluation of nodal status 3 years Show that the algorithm of high-definition positron emission tomography (PET) to 18Fluoro-deoxy-glucose (18FDG) is greater than a classical algorithm in the diagnosis of lymph node metastases.
- Secondary Outcome Measures
Name Time Method Information on lymph node status in patients with breast cancer. 3 years Show that scintigraphy performed on a FDG positron camera equipped with a reconstruction algorithm for high-definition can provide reliable information on lymph node status in patients with breast cancer and determine the minimum size of lymph node metastatic lesions.
Trial Locations
- Locations (1)
Centre François Baclesse
🇫🇷Caen, France